New Delhi: Krishna Prasad Chigurupati, one of the promoters of Granules India, on Wednesday sold 3.09 per cent stake in the company for Rs 304 crore through an open market transaction.According to block deal data available on NSE, Krishna Prasad Chigurupati sold 75 lakh shares, equivalent to...
New Delhi, Drug firm Granules India on Wednesday reported 8 per cent rise in consolidated profit after tax at Rs 130 crore for the fourth quarter ending March 31, 2024.The pharmaceutical company had reported a profit after tax (PAT) of Rs 120 crore for January-March FY23.Revenue from...
New Delhi: Drug firm Granules India on Tuesday said it has received approval from the US health regulator to market a drug used to prevent or treat arthritis attacks.The company's wholly owned foreign subsidiary, Granules Pharmaceuticals, Inc., has received approval from the US Food and Drug...